Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinib

被引：3
|
作者：
Loglisci, Giuseppina [1 ]
Breccia, Massimo [1 ]
Nanni, Mauro [1 ]
Mancini, Marco [1 ]
De Cuia, Rosa [1 ]
Cannella, Laura [1 ]
Salaroli, Adriano [1 ]
Federico, Vincenzo [1 ]
Serrao, Alessandra [1 ]
Loglisci, Maria Giovanna [1 ]
Santopietro, Michelina [1 ]
Alimena, Giuliana [1 ]
机构：
[1] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Rome, Italy
来源：
LEUKEMIA & LYMPHOMA | 2011年 / 52卷 / 07期
关键词：
BCR-ABL; GENE AMPLIFICATION; EXPRESSION; MESYLATE; THERAPY; ST1571; CELLS;
D O I：
10.3109/10428194.2011.565394
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1372 / 1375
页数：4
相关论文
共 50 条
  • [41] Philadelphia chromosome mosaicism at diagnosis in chronic myeloid leukemia: Clinical correlates and effect on imatinib mesylate treatment outcome
    Landstrom, Andrew P.
    Knudson, Ryan A.
    Dewald, Gordon W.
    Ketterling, Rhett P.
    Tefferi, Ayalew
    LEUKEMIA & LYMPHOMA, 2007, 48 (11) : 2137 - 2140
  • [42] Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib
    Hayashi, Yoshiki
    Nakamae, Hirohisa
    Katayama, Takako
    Nakane, Takahiko
    Koh, Hideo
    Nakamae, Mika
    Hirose, Asao
    Hagihara, Kiyoyuki
    Terada, Yoshiki
    Nakao, Yoshitaka
    Hino, Masayuki
    LEUKEMIA & LYMPHOMA, 2012, 53 (06) : 1084 - 1089
  • [43] Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib
    Cortes, Jorge E.
    Khoury, Hanna J.
    Kantarjian, Hagop M.
    Lipton, Jeff H.
    Kim, Dong-Wook
    Schafhausen, Philippe
    Matczak, Ewa
    Leip, Eric
    Noonan, Kay
    Bruemmendorf, Tim H.
    Gambacorti-Passerini, Carlo
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (12) : 1206 - 1214
  • [44] Duplication of Philadelphia chromosome and trisomy of chromosome 21 in a pediatric patient with acute lymphoblastic leukemia
    Katsibardi, Katerina
    Braoudaki, Maria
    Papadhimitriou, Stefanos I.
    Karamolegou, Kalliopi
    Tzortzatou-Stathopoulou, Fotini
    MEDICAL ONCOLOGY, 2011, 28 : S501 - S504
  • [45] Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
    Hoyle, Martin
    Rogers, Gabriel
    Moxham, Tiffany
    Liu, Zulian
    Stein, Ken
    VALUE IN HEALTH, 2011, 14 (08) : 1057 - 1067
  • [46] Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients
    Chandrasekhar, Chodimella
    Kumar, Pasupuleti Santhosh
    Sarma, Potukuchi Venkata Gurunadha Krishna
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [47] Dynamics and Management of Cytopenias Associated With Dasatinib Therapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Imatinib Failure
    Quintas-Cardama, Alfonso
    Santos, Fabio Pires De Souza
    Kantarjian, Hagop
    O'Brien, Susan
    Faderl, Stefan
    Awais, Ahmed
    Borthakur, Gautam
    Cortes, Jorge
    CANCER, 2009, 115 (17) : 3935 - 3943
  • [48] Evaluation of T315I mutation frequency in chronic myeloid leukemia patients after imatinib resistance
    Chahardouli, Bahram
    Zaker, Farhad
    Mousavi, Seied Asadollah
    Kazemi, Ahmad
    Ostadali, Mohammadreza
    Nadali, Fatemeh
    Rostami, Shahrbano
    Alimoghaddam, Kamran
    Ghavamzade, Ardeshir
    HEMATOLOGY, 2013, 18 (03) : 158 - 162
  • [49] Downregulation of miR-451 in Tunisian chronic myeloid leukemia patients: potential implication in imatinib resistance
    Soltani, Ismael
    Douzi, Kais
    Gharbi, Hanen
    Benhassine, Islem
    Teber, Mouheb
    Amouri, Hassiba
    Othman, Hind Ben Hadj
    Farrah, Ahlem
    Ben Lakhel, Raihane
    Abbes, Salem
    Menif, Samia
    HEMATOLOGY, 2017, 22 (04) : 201 - 207
  • [50] Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population
    Cereja-Pantoja, Karla Beatriz Cardias
    Azevedo, Tereza Cristina de Brito
    Vinagre, Lui Wallacy Morikawa Souza
    de Moraes, Francisco Cezar Aquino
    Nunes, Giovanna Gilioli da Costa
    Monte, Natasha
    de Alcantara, Angelica Leite
    Cohen-Paes, Amanda
    Fernandes, Marianne Rodrigues
    dos Santos, Sidney Emanuel Batista
    de Assumpcao, Paulo Pimentel
    dos Santos, Andrea Kely Ribeiro
    Burbano, Rommel Mario Rodriguez
    Guerrero, Raquel Cruz
    Carracedo, Angel
    dos Santos, Ney Pereira Carneiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (03) : 387 - 395
12345